LEVRAE remains the controlled source for assessments and sensitive practitioner workflows. LEVRAE receives only contractually permitted, purpose-limited enterprise signals.
Consent and separation
Explicit consent where required, data minimization, independent permissions and revocation workflows. No clinical notes in investor data rooms.
Aggregation and security
Minimum-group thresholds, suppression for small cohorts, encrypted transfer, access logs, retention limits and no re-identification.
Human oversight
Professional interpretation, auditability, bias evaluation, appeal/correction processes and no automated employment or investment eligibility decisions.
How each engagement is deployed
Phase 1
Data dictionary, permissions, purpose mapping and legal/privacy review.
Phase 2
Secure aggregated reporting API and consent enforcement.
Phase 3
LEVI dashboards, methodology disclosures and analyst review.
Phase 4
Pilot evaluation, quality testing and monitored rollout.